Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Peripheral Nervous System Diseases 3Pain 3Breast Neoplasms 3Neurotoxicity Syndromes 2Colorectal Neoplasms 2Urinary Incontinence 1Prostatic Neoplasms 1Neoplasms 1Hematologic Neoplasms 1Emergence Delirium 1Cancer Pain 1CIPN 1Acute Pain 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Letrozole 221Capecitabine 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 132Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Duloxetine Hydrochloride × Clear all
NCT04732455 2022-07-11

TIPN

Alexandria University

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT01912612 2020-08-06

Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain

University of Michigan Rogel Cancer Center

Phase 2 Completed
82 enrolled 26 charts
Breast

Breast Neoplasms, Pain

NCT01028352 2013-08-08

Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain

University of Michigan Rogel Cancer Center

Phase NA Completed
35 enrolled 6 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡